Insulet Corporation management check
PODD · Health Care · Health Care Equipment · CEO Ashley McEvoy
Filings as of
Closest peers in Health Care Equipment
- 153ISRGIntuitive Surgical72
- 158ABTAbbott Laboratories72
- 162SYKStryker Corporation71
- 185IDXXIdexx Laboratories69
- 199BSXBoston Scientific68
- 250RVTYRevvity64
- 284RMDResMed63
- 286GEHCGE HealthCare62
- 322STESteris60
- 353BDXBecton Dickinson58
The seven checks
- GoodBeat its chosen peers
Have owners done well?
What $100 became since fiscal 2021
6566thDetail
$100 invested at the start of fiscal 2021 grew to $111, against $99 for the peer group the company picked itself.
- WatchPay only loosely tracked returns
Does pay follow performance?
Pay actually paid $100 value, each on its own scale
6220thDetail
Over 5 years, the CEO's pay actually paid (equity valued at the share price) had a correlation of 0.23 with shareholder return. 1 means pay moved in step; below 0, the opposite way.
- Flag7.6% of net income
What does the CEO cost owners?
$18.9m pay · $247.1m net income, FY2025
016thDetail
$18.9m of reported pay in fiscal 2025, against $247.1m of net income.
- GoodInsiders are buying
Do they own the stock?
23,731 shares ≈ $3.5m
6 mo: ▲ $1.1m bought · ▼ $60k sold
2022ndDetail
The CEO holds 23,731 shares, directly or through trusts (unvested awards not counted): about 0.2 years of pay. 3 insiders bought $1.1m on the open market in the last six months, with their own money, near the lows. Sales: $60k.
- GoodShare count shrinking
Are owners being diluted?
Diluted shares −1.2% a year; flagged above +2%
Stock pay 2.3% of revenue
6555thDetail
Diluted shares changed -1.2% a year over the last three fiscal years. Stock-based pay was 2.3% of revenue in the latest year.
- Flag3 CEOs in the pay table
Is leadership stable?
15 filings under 8-K 5.02 in 3 years
CEOs: Shacey Petrovic, James Hollingshead, Ashley McEvoy
04thDetail
CEOs in the pay table: Shacey Petrovic, James Hollingshead, Ashley McEvoy. 15 filings under 8-K item 5.02 (officers or directors leaving or joining, or new pay arrangements) in the last 3 years.
- FlagRed flags on file
Are the books clean?
Since 2021
- 0Restated
- 2Auditor changes
- 0Late filings
- 010-K amended
152ndDetail
2 auditor changes (8-K 4.01) since 2021.
Reading the scores
Each check scored 0–100 from its own figure. The tick is the Health Care median; the ordinal is the share of ranked S&P 500 companies it matches or beats.
Hover a chart for its figures. Detail has the full reading.
Pay versus performance
From the proxy statement filed April 6, 2026.
Pay tied most to Adjusted revenue
Other key measuresAdjusted RevenueAdjusted EBITRelative TSR
Show the figures
| Fiscal year | CEO | CEO pay | Actually paid | Other executives (avg) | $100 became | Peers | Net income |
|---|---|---|---|---|---|---|---|
| 2025 | Ashley McEvoy, James Hollingshead | $18.9m | $25.2m | $3.8m | $111 | $99 | $247.1m |
| 2024 | James Hollingshead | $13.3m | $32.7m | $3.3m | $102 | $81 | $418.3m |
| 2023 | James Hollingshead | $12.4m | $12.8m | $2.8m | $85 | $82 | $206.3m |
| 2022 | James Hollingshead, Shacey Petrovic | $15.7m | $16.1m | $3.4m | $115 | $77 | $4.6m |
| 2021 | Shacey Petrovic | $9.7m | $9.1m | $2.6m | $104 | $96 | $16.8m |
Insiders and the CEO's stake
- President and CEO
- Ashley McEvoy
- Shares held
- 23,731
- At that filing's price
- ≈ $3.5m
- Latest Form 4
- Aug 21, 2026
3 insiders bought $1.1m on the open market in the last six months, with their own money, near the lows. Sales: $60k.
Open-market trades by officers and directors since May 21, 2026.
- BoughtElizabeth H WeathermanDirector$497kJun 3, 2026
- BoughtTimothy C. StonesiferDirector$400kJun 3, 2026
- BoughtAshley McEvoyPresident and CEO$162kAug 21, 2026
- SoldLuciana BorioDirector$60kJun 3, 2026
Leadership and governance on file
All 25 filings
- Sep 16, 2026Leadership change8-K 5.02
- Sep 10, 2026Leadership change8-K 5.02
- Jun 25, 2026Leadership change8-K 5.02
- Mar 4, 2026Leadership change8-K 5.02
- Feb 24, 2026Auditor change8-K/A 4.01
- Dec 19, 2025Auditor change8-K 4.01
- Dec 17, 2025Leadership change8-K 5.02
- Oct 23, 2025Leadership change8-K 5.02
- Sep 16, 2025Leadership change8-K 5.02
- May 28, 2025Leadership change8-K 5.02
- Apr 28, 2025Leadership change8-K 5.02
- Apr 9, 2025Leadership change8-K/A 5.02
- Mar 17, 2025Leadership change8-K 5.02
- Feb 21, 2025Leadership change8-K 5.02
- Mar 20, 2024Leadership change8-K 5.02
- Mar 1, 2024Leadership change8-K 5.02
- Jan 18, 2024Leadership change8-K 5.02
- Oct 3, 2023Leadership change8-K 5.02
- May 4, 2023Leadership change8-K 5.02
- Feb 22, 2023Leadership change8-K 5.02
- Dec 14, 2022Leadership change8-K 5.02
- May 6, 2022Leadership change8-K 5.02
- Mar 1, 2022Leadership change8-K 5.02
- Feb 24, 2022Leadership change8-K 5.02
- Feb 7, 2022Leadership change8-K 5.02
Latest shareholder vote results: May 21, 2026, including the say-on-pay vote.
Where the money went
2021–2025: $59.6m returned to owners in buybacks and dividends, 7% of net income, and $255.7m of pay in stock.
Show the figures
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $1.0bn | $1.1bn | $1.7bn | $2.1bn | $2.7bn |
| Net income | $16.8m | $4.6m | $206.3m | $418.3m | $247.1m |
| Stock-based pay | $34.4m | $40.9m | $48.4m | $69.3m | $62.7m |
| Buybacks | — | — | $0 | $0 | $59.6m |
| Dividends | — | — | — | — | — |
| Diluted shares | 69m | 70m | 74m | 74m | 72m |
Educational only, not investment advice. Figures are as filed with the SEC: pay from the proxy's pay-versus-performance table, capital allocation from 10-K XBRL data, insider trades from Form 4s over the last six months, events from the last 5 years of filings. The peer group is the one the company chose. See the method.